Sort
10,766 grants matching “checkpoint inhibitor”
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques
$812,443Guido Silvestri · Emory University · R01 · FY2018 · AI
Epigenetic Therapy for Thoracic Malignancies
$811,718David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Treg-depleting immunotherapy
$811,405Peter David Suzdak · Sonoval Llc · R44 · FY2022 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$810,231Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$809,851Peng Wu · Scripps Research Institute, The · R01 · FY2023 · AI
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$809,851Peng Wu · Scripps Research Institute, The · R01 · FY2024 · AI
AAV-delivered HIV inhibitors for SHIV therapy
$809,507Matthew Ryan Gardner · Emory University · R01 · FY2023 · DA
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer
$809,248Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer
$809,234Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
AAV-delivered HIV inhibitors for SHIV therapy
$808,489Matthew Ryan Gardner · Emory University · R01 · FY2024 · DA
Immunology of aging and immunotherapy of aging-associated diseases
$807,712Arya Biragyn · National Institute On Aging · ZIA · FY2025 · AG
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
$807,680Stephen C Mack · St. Jude Children'S Research Hospital · U01 · FY2023 · CA
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$805,488Justin M Balko · Vanderbilt University Medical Center · R01 · FY2025 · HL
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$804,594Andrew Sikora · Baylor College Of Medicine · U01 · FY2018 · DE
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$804,578Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC
Development of Salmonella for cancer therapeutics
$804,278Olivia Steele-Mortimer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Gene Expression At The Beginning Of Mammalian Development
$804,196Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Initiation Of DNA Replication In Mammalian Chromosomes
$804,196Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
$803,945Ramaswamy Govindan · Washington University · U01 · FY2025 · CA
Reprograming the tumor microenvironment to overcome multiple primary and acquired immune resistance mechanisms in ovarian cancer
$802,002Kunle O Odunsi · Roswell Park Cancer Institute Corp · U01 · FY2019 · CA
Initiation of anti-islet autoimmunity: Regulation of MHC class II expression in the islet microenvironment
$801,662Luc Teyton · Scripps Research Institute, The · R01 · FY2025 · DK
Immune response to MCMV infection in the salivary glands
$801,662Laurent Brossay · Brown University · R01 · FY2023 · AI
AAV-delivered HIV inhibitors for SHIV therapy
$801,157Matthew Ryan Gardner · Emory University · R01 · FY2025 · DA
EFFECT OF A MULTIPEPTIDE KRAS VACCINE IN THE PREVENTION OF PANCREATIC CANCER DRIVEN BY KRAS ONCOPROTEIN HHSN2612015000371 TORFP: 2017-E02
$800,994Ming You · Medical College Of Wisconsin · N01 · FY2017 · CA
Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques
$800,953Guido Silvestri · Emory University · R01 · FY2016 · AI